Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit

Hepatology

Volumn 50, Issue 2, 2009, Pages 400-406

  Lucey, Michael R ^a   Schaubel, Douglas E ^b,c   Guidinger, Mary K ^c,d   Tome, Santiago ^e   Merion, Robert M ^d,f  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Scientific Registry of Transplant Recipients   (United States)

^d ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; GRAFT SURVIVAL; HEPATITIS C; HOSPITAL PATIENT; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MODEL FOR END STAGE LIVER DISEASE; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; COHORT ANALYSIS; HOSPITAL ADMISSION; PROPORTIONAL HAZARDS MODEL;

ADULT; COHORT STUDIES; HEPATITIS C; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; WAITING LISTS;

EID: 68949196127     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23007     Document Type: Article

References (24)

1. United Network for Organ Sharing. Available at: http://www.unos.org. Accessed July 30, 2008.
2. National Institutes of Health Consensus Development Conference on Liver Transplantation. Sponsored by the National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases and the National Institutes of Health Office of Medical Applications of Research. HEPATOLOGY 1984;4(Suppl 1):1S-110S.
3. Starzl TE, Van Thiel D, Tzakis AG, Iwatsuki S, Todo S, Marsh JW, et al. Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988;260:2542-2544. (Pubitemid 18257034)
4. Lucey MR, Merion RM, Henley KS, Campbell DA Jr, Turcotte JG, Nostrant TT, et al. Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 1992;102:1736-1741.
5. Lucey MR, Carr K, Beresford TP, Lucey MR, Carr K, Beresford TP, et al. Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. HEPATOLOGY 1997;25:1223-1227.
6. Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007;13:197-205.
7. Martin P, Munoz SJ, Di Bisceglie AM, Rubin R, Waggoner JG, Armenti VT, et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. HEPATOLOGY 1991;13:719-721.
8. Terrault NA, Wright TL, Pereira BJ. Hepatitis C infection in the transplant recipient. Infect Dis Clin North Am 1995;9:943-964.
9. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896. (Pubitemid 34267271)
10. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004;10:886-897. (Pubitemid 38979259)
11. Poynard T, Barthelemy P, Fratte S, Boudjema K, Doffoel M, Vanemmens C, et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet 1994;344:502-507. (Pubitemid 24261567)
12. Poynard T, Naveau S, Doffoel M, Boudjema K, Vanlemmens C, Mantion G, et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group. J Hepatol 1999;30:1130-1137. (Pubitemid 29278759)
13. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-313.
14. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008;8:419-425. (Pubitemid 351175358)
15. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
16. Schaubel DE, Wolfe RA, Port FK. A sequential stratification method for estimating the effect of a time-dependent experimental treatment in observational studies. Biometrics. 2006;62:910-917.
17. Barshes NR, Horwitz IB, Franzini L, Vierling JM, Goss JA. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant 2007;7:1265-1270. (Pubitemid 46643109)
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001;33:464-470. (Pubitemid 32119037)
19. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896. (Pubitemid 34267271)
20. DiMartini A, Day N, Dew MA, Javed L, Fitzgerald MG, Jain A, et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 2006;12:813-820.
21. Lucey MR. Liver transplantation for alcoholic liver disease: past, present, and future. Liver Transpl 2007;13:190-192. (Pubitemid 46351642)
22. Pfitzmann R, Benscheidt B, Langrehr JM, Schumacher G, Neuhaus R, Neuhaus P. Trends and experiences in liver retransplantation over 15 years. Liver Transpl 2007;13:248-257. (Pubitemid 46351651)
23. Everson GT, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B, et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. HEPATOLOGY 2005;42:255-262. (Pubitemid 41061075)
24. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018-1026.